Salveen Richter
Stock Analyst at Goldman Sachs
(2.31)
# 2,551
Out of 4,734 analysts
193
Total ratings
38.89%
Success rate
-0.3%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics | Maintains: Neutral | $20 → $12 | $9.50 | +26.32% | 8 | Jan 14, 2025 | |
| APLS Apellis Pharmaceuticals | Downgrades: Neutral | $36 | $29.94 | +20.26% | 7 | Dec 17, 2024 | |
| QURE uniQure | Maintains: Neutral | $9 → $20 | $14.05 | +42.35% | 7 | Dec 12, 2024 | |
| GILD Gilead Sciences | Maintains: Neutral | $74 → $84 | $91.84 | -8.54% | 4 | Nov 7, 2024 | |
| INCY Incyte | Maintains: Neutral | $63 → $70 | $71.93 | -2.68% | 9 | Oct 30, 2024 | |
| MRNA Moderna | Maintains: Buy | $178 → $139 | $34.06 | +308.10% | 8 | Sep 16, 2024 | |
| RLAY Relay Therapeutics | Reinstates: Buy | $20 | $4.46 | +348.43% | 2 | Sep 10, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $198 → $370 | $246.27 | +50.24% | 5 | Aug 16, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $67 → $76 | $40.00 | +90.00% | 3 | Aug 2, 2024 | |
| IONS Ionis Pharmaceuticals | Maintains: Sell | $33 → $37 | $31.43 | +17.72% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $7.08 | +55.37% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $32.42 | +63.48% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $50 | $21.93 | +128.00% | 4 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $5 | $6.81 | -26.58% | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $272.11 | +28.62% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $81 | $4.58 | +1,668.56% | 3 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $422.00 | +32.46% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $5 | $2.61 | +91.57% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $15.16 | -67.02% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $188 → $215 | $118.00 | +82.20% | 3 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $9.41 | +16.90% | 1 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.82 | +1,603.30% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $291.45 | -22.80% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $2.89 | +661.25% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.58 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.96 | +504.84% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.99 | +1,313.28% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $6.53 | +37.83% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $1.53 | +96.08% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $17.57 | -31.70% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $3.16 | +89.87% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $61.53 | -30.12% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $370 | $140.55 | +163.25% | 2 | Oct 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $796 → $970 | $681.58 | +42.32% | 9 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $40 → $60 | $8.35 | +618.56% | 6 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $4 | $0.55 | +628.60% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $52 → $46 | $40.53 | +13.50% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.48 | +35.14% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $6.57 | +1,422.07% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $28 | $14.03 | +99.57% | 2 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.60 | +4,900.00% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $110.33 | -54.68% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $19.56 | +130.06% | 1 | Mar 17, 2020 |
Intellia Therapeutics
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $9.50
Upside: +26.32%
Apellis Pharmaceuticals
Dec 17, 2024
Downgrades: Neutral
Price Target: $36
Current: $29.94
Upside: +20.26%
uniQure
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $14.05
Upside: +42.35%
Gilead Sciences
Nov 7, 2024
Maintains: Neutral
Price Target: $74 → $84
Current: $91.84
Upside: -8.54%
Incyte
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $71.93
Upside: -2.68%
Moderna
Sep 16, 2024
Maintains: Buy
Price Target: $178 → $139
Current: $34.06
Upside: +308.10%
Relay Therapeutics
Sep 10, 2024
Reinstates: Buy
Price Target: $20
Current: $4.46
Upside: +348.43%
Alnylam Pharmaceuticals
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $246.27
Upside: +50.24%
Ultragenyx Pharmaceutical
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $40.00
Upside: +90.00%
Ionis Pharmaceuticals
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $31.43
Upside: +17.72%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $7.08
Upside: +55.37%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $32.42
Upside: +63.48%
Feb 29, 2024
Maintains: Buy
Price Target: $73 → $50
Current: $21.93
Upside: +128.00%
Feb 16, 2024
Maintains: Neutral
Price Target: $11 → $5
Current: $6.81
Upside: -26.58%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $272.11
Upside: +28.62%
Feb 7, 2024
Reinstates: Buy
Price Target: $81
Current: $4.58
Upside: +1,668.56%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $422.00
Upside: +32.46%
Sep 13, 2023
Downgrades: Neutral
Price Target: $5
Current: $2.61
Upside: +91.57%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $15.16
Upside: -67.02%
Jun 23, 2023
Maintains: Buy
Price Target: $188 → $215
Current: $118.00
Upside: +82.20%
Mar 2, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $9.41
Upside: +16.90%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.82
Upside: +1,603.30%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $291.45
Upside: -22.80%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $2.89
Upside: +661.25%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.58
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.96
Upside: +504.84%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.99
Upside: +1,313.28%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $6.53
Upside: +37.83%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $1.53
Upside: +96.08%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $17.57
Upside: -31.70%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $3.16
Upside: +89.87%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $61.53
Upside: -30.12%
Oct 26, 2022
Upgrades: Buy
Price Target: $370
Current: $140.55
Upside: +163.25%
Oct 3, 2022
Maintains: Buy
Price Target: $796 → $970
Current: $681.58
Upside: +42.32%
Aug 19, 2022
Maintains: Sell
Price Target: $40 → $60
Current: $8.35
Upside: +618.56%
May 24, 2022
Maintains: Neutral
Price Target: $7 → $4
Current: $0.55
Upside: +628.60%
May 24, 2022
Maintains: Neutral
Price Target: $52 → $46
Current: $40.53
Upside: +13.50%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.48
Upside: +35.14%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $6.57
Upside: +1,422.07%
May 12, 2022
Maintains: Neutral
Price Target: $48 → $28
Current: $14.03
Upside: +99.57%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.60
Upside: +4,900.00%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $110.33
Upside: -54.68%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $19.56
Upside: +130.06%